Obsidian Therapeutics, Inc. financial statements
Obsidian Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 100.61M | EODHD |
| Cash and equivalents | USD 40.41M | EODHD |
| Total debt | USD 4.28M | EODHD |
Obsidian Therapeutics, Inc. financials on 6ix · Obsidian Therapeutics, Inc. on 6ix